These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30906294)

  • 1. Corrigendum: Genetic Removal of the CH1 Exon Enables the Production of Heavy Chain-Only IgG in Mice.
    Zhang T; Cheng X; Yu D; Lin F; Hou N; Cheng X; Hao S; Wei J; Ma L; Fu Y; Ma Y; Ren L; Han H; Yu S; Yang X; Zhao Y
    Front Immunol; 2019; 10():398. PubMed ID: 30906294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Removal of the CH1 Exon Enables the Production of Heavy Chain-Only IgG in Mice.
    Zhang T; Cheng X; Yu D; Lin F; Hou N; Cheng X; Hao S; Wei J; Ma L; Fu Y; Ma Y; Ren L; Han H; Yu S; Yang X; Zhao Y
    Front Immunol; 2018; 9():2202. PubMed ID: 30319646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Camel heavy chain antibodies against prostate-specific membrane antigen.
    Evazalipour M; Tehrani BS; Abolhassani M; Morovvati H; Omidfar K
    Hybridoma (Larchmt); 2012 Dec; 31(6):424-9. PubMed ID: 23244321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of effector functions related motifs, complement activation and hemagglutinating activities in Lama glama heavy chain antibodies.
    Saccodossi N; De Simone EA; Leoni J
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):323-31. PubMed ID: 22197565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BiP and immunoglobulin light chain cooperate to control the folding of heavy chain and ensure the fidelity of immunoglobulin assembly.
    Lee YK; Brewer JW; Hellman R; Hendershot LM
    Mol Biol Cell; 1999 Jul; 10(7):2209-19. PubMed ID: 10397760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
    Bannas P; Hambach J; Koch-Nolte F
    Front Immunol; 2017; 8():1603. PubMed ID: 29213270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
    Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
    Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodies.
    Wu X; Sereno AJ; Huang F; Zhang K; Batt M; Fitchett JR; He D; Rick HL; Conner EM; Demarest SJ
    MAbs; 2015; 7(2):364-76. PubMed ID: 25611120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Single-domain antibody - advances in research and application].
    Kang X; Cao J; Zhang B; Yuan Q
    Sheng Wu Gong Cheng Xue Bao; 2018 Dec; 34(12):1974-1984. PubMed ID: 30584708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications.
    Gonzalez-Sapienza G; Rossotti MA; Tabares-da Rosa S
    Front Immunol; 2017; 8():977. PubMed ID: 28871254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Cloning and Production of Human Heavy-Chain-Only Antibodies from Murine Transgenic Plasma Cells.
    Drabek D; Janssens R; de Boer E; Rademaker R; Kloess J; Skehel J; Grosveld F
    Front Immunol; 2016; 7():619. PubMed ID: 28066429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An aberrant splicing using a 3' cryptic splice site within the CH1 exon induces truncated mu-chain production.
    Komori T; Sugiyama H
    Immunology; 1995 May; 85(1):166-70. PubMed ID: 7635518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The porcine Ig delta gene: unique chimeric splicing of the first constant region domain in its heavy chain transcripts.
    Zhao Y; Pan-Hammarström Q; Kacskovics I; Hammarström L
    J Immunol; 2003 Aug; 171(3):1312-8. PubMed ID: 12874220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Analysis of Immune Repertoires between Bactrian Camel's Conventional and Heavy-Chain Antibodies.
    Li X; Duan X; Yang K; Zhang W; Zhang C; Fu L; Ren Z; Wang C; Wu J; Lu R; Ye Y; He M; Nie C; Yang N; Wang J; Yang H; Liu X; Tan W
    PLoS One; 2016; 11(9):e0161801. PubMed ID: 27588755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of heavy and light chain assembly by modification of heavy chain constant region 1 (CH1): Application for the construction of an anti-paclitaxel fragment antigen-binding (Fab) antibody.
    Yusakul G; Sakamoto S; Tanaka H; Morimoto S
    J Biotechnol; 2018 Dec; 288():41-47. PubMed ID: 30389640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library.
    Yan J; Wang P; Zhu M; Li G; Romão E; Xiong S; Wan Y
    J Nanobiotechnology; 2015 May; 13():33. PubMed ID: 25944262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1.
    Chen W; Bardhi A; Feng Y; Wang Y; Qi Q; Li W; Zhu Z; Dyba MA; Ying T; Jiang S; Goldstein H; Dimitrov DS
    MAbs; 2016; 8(4):761-74. PubMed ID: 26963639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of ELISAs for the measurement of IgM and IgG subclasses in sera from llamas (Lama glama) and assessment of the humoral immune response against different antigens.
    De Simone EA; Saccodossi N; Ferrari A; Leoni J
    Vet Immunol Immunopathol; 2008 Nov; 126(1-2):64-73. PubMed ID: 18692907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: Sialyllactose and Galactooligosaccharides Promote Epithelial Barrier Functioning and Distinctly Modulate Microbiota Composition and Short Chain Fatty Acid Production
    Perdijk O; van Baarlen P; Fernandez-Gutierrez MM; van den Brink E; Schuren FHJ; Brugman S; Savelkoul HFJ; Kleerebezem M; van Neerven RJJ
    Front Immunol; 2019; 10():762. PubMed ID: 31024573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.